Literature DB >> 11155144

The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis.

F A Kemperman1, J A Weber, J Gorgels, A P van Zanten, R T Krediet, L Arisz.   

Abstract

OBJECTIVE: Analysis of the interference of ketoacids on various routine plasma creatinine assays during a clinical episode of diabetic ketoacidosis (DKA).
DESIGN: Observational study. Blood samples were drawn before, during and after standard in-hospital treatment. Plasma creatinine was measured with two dissimilar enzymatic assays (creatininase PAP + and creatinine iminohydrolase Serapak), a kinetic alkaline picrate method (Jaffé) and a high-performance liquid chromatography (HPLC) procedure. Acetoacetate and beta-hydroxybutyrate were analysed by enzymatic methods.
SETTING: Department of Medicine, University Hospital.
SUBJECTS: Nine patients who experienced 10 episodes of DKA. MAIN OUTCOME MEASURES: Agreement of the routine plasma creatinine assays with HPLC and analysis of possible interferents.
RESULTS: At presentation, the Jaffé assay gave falsely high values of plasma creatinine (median 99 micromol L(-1)), in contrast to the PAP+ (median 60.5 micromol L(-1)) and HPLC assays (median 67.5 micromol L(-1)). This positive error decreased during treatment. This was due to a decrease in acetoacetate, as the positive error by the Jaffé method correlated with the acetoacetate concentration (r = 0.79, P < 0.0001). In the multiple regression analysis, beta-hydroxybutyrate caused no additional interference by the Jaffé assay, confirmed by in vitro experiments. Analysis of agreement showed that the difference between PAP+ and HPLC creatinine was -4.6 +/- 3.0 micromol L(-1) (mean +/- SD), and 2.0 +/- 5.3 micromol L(-1) between Serapak and HPLC. This was statistically significant, but clinically negligible.
CONCLUSION: Acetoacetate caused severe interference of the alkaline picrate (Jaffé) assay, which might influence therapeutic decisions at the start of diabetic ketoacidosis. Enzymatic assays lack this interference.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11155144     DOI: 10.1046/j.1365-2796.2000.00768.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  5 in total

1.  Interference of ketone bodies on laboratory creatinine measurement in children with DKA: a call for change in testing practices.

Authors:  Damian Feldman-Kiss; Dailin Li; Richard Cleve; Graham Sinclair; Joshua A Dubland; Li Wang
Journal:  Pediatr Nephrol       Date:  2021-11-10       Impact factor: 3.651

2.  Incidence and long-term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: A retrospective cohort study.

Authors:  Aksha Ramaesh
Journal:  J Intensive Care Soc       Date:  2016-04-25

3.  Unexplained Metabolic Acidosis: Alcoholic Ketoacidosis or Propylene Glycol Toxicity.

Authors:  Fanny de Landsheere; Franck Saint-Marcoux; Vincent Haufroid; Sylvain Dulaurent; Joseph P Dewulf; Lidvine Boland; Pierre-François Laterre; Philippe Hantson
Journal:  J Med Toxicol       Date:  2022-01-18

4.  Diagnostic Performance of Height-Estimated Baseline Creatinine in Diagnosing Acute Kidney Injury in Children with Type 1 Diabetes Mellitus Onset.

Authors:  Stefano Guarino; Giulio Rivetti; Anna Di Sessa; Maeva De Lucia; Pier Luigi Palma; Emanuele Miraglia Del Giudice; Cesare Polito; Pierluigi Marzuillo
Journal:  Children (Basel)       Date:  2022-06-16

5.  Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Authors:  Gayle M Lorenzi; Barbara H Braffett; Valerie L Arends; Ronald P Danis; Lisa Diminick; Kandace A Klumpp; Anthony D Morrison; Elsayed Z Soliman; Michael W Steffes; Patricia A Cleary
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.